← Back to Search

NTM Monitoring for Neonatal Hypothermia

N/A
Waitlist Available
Led By Rebecca Richards-Kortum, PhD
Research Sponsored by William Marsh Rice University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up <72 hours
Awards & highlights

Study Summary

This study is evaluating whether a new temperature sensor may be able to help prevent infant hypothermia.

Eligible Conditions
  • Neonatal Hypothermia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~<72 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and <72 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Temperature measurement accuracy

Trial Design

1Treatment groups
Experimental Treatment
Group I: Neonatal Temperature MonitorExperimental Treatment1 Intervention
One or more test devices (NTM, Bempu, Thermospot) will be attached to the infant in the neonatal intensive care unit (NICU) or KMC ward along with the Philips Intellivue patient monitor. Temperature will be monitored continuously using each device for up to 72 hours.

Find a Location

Who is running the clinical trial?

Kamuzu University of Health SciencesOTHER
66 Previous Clinical Trials
81,725 Total Patients Enrolled
1 Trials studying Neonatal Hypothermia
150 Patients Enrolled for Neonatal Hypothermia
University of Malawi College of MedicineOTHER
56 Previous Clinical Trials
65,645 Total Patients Enrolled
1 Trials studying Neonatal Hypothermia
150 Patients Enrolled for Neonatal Hypothermia
William Marsh Rice UniversityLead Sponsor
45 Previous Clinical Trials
27,703 Total Patients Enrolled
3 Trials studying Neonatal Hypothermia
330 Patients Enrolled for Neonatal Hypothermia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~20 spots leftby Apr 2025